Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05546359 · ClinicalTrials.gov registry record · Phase 2

Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients

A Phase 2 study of Nausea and Vomiting, Postoperative, sponsored by Acacia Pharma.

Completed
Registry status
Phase 2
Development phase
453
Enrollment target
14
Study locations

NCT05546359 is a Phase 2 study of Nausea and Vomiting, Postoperative that has completed, run by Acacia Pharma. The registered enrollment target is 453 participants, above the 177-participant average among 5 other Nausea and Vomiting, Postoperative trials with a reported enrollment target (156% higher). The trial reports 14 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05546359, a Phase 2 study of Nausea and Vomiting, Postoperative, has completed, sponsored by Acacia Pharma.

COMPLETED
Registry status
Phase 2
Development phase
453 participants
Enrollment target
14
Study locations

Study Summary

Randomized, double-blind, pediatric trial of amisulpride for prophylaxis of post operative nausea and vomiting

Conditions Studied

Nausea and Vomiting, Postoperative

Interventions

  • DRUG Dexamethasone
  • DRUG Amisulpride Injection

Study Locations (14)

Other

  • HCL - Hôpital Mère Enfant - Bron
  • CHU Strasbourg - Hopital Hautepierre - Strasbourg
  • Helios Klinikum Aue - Aue

Pennsylvania

  • The Children's Hospital of Philadelphia (CHOP) - Philadelphia
  • UPMC Children's Hospital of Pittsburgh - Pittsburgh

Hesse

  • Ambulantes Operieren Marburg - Marburg
  • Universitaetsklinikum Giessen und Marburg GmbH - Marburg

Alabama

  • Helen Keller Hospital - Sheffield

Georgia

  • Emory Healthcare - Emory University Hospital - Atlanta

Minnesota

  • University of Minnesota Masonic Children's Hospital - Minneapolis

Ontario

  • The Hospital for Sick Children - Toronto

Quebec

  • McGill University Health Centre - The Montréal Children's Hospital - Montreal

Trial Details

FieldValue
Enrollment Target 453 participants
Start Date 2024-01-18
Est. Completion 2025-06-03
Phase Phase 2

Sponsor

Acacia Pharma

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05546359

The ClinicalTrials.gov registry entry for NCT05546359 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 453 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 177-participant average among 5 other Nausea and Vomiting, Postoperative trials with a reported enrollment target (156% higher). The listed sponsor is Acacia Pharma, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nausea and Vomiting, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.

NCT05546359 reports 14 study locations spanning 10 distinct geographic areas - top geographies include Other, Pennsylvania, Hesse.

Frequently Asked Questions

What is clinical trial NCT05546359 about?

NCT05546359 is a clinical study titled "Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients". Randomized, double-blind, pediatric trial of amisulpride for prophylaxis of post operative nausea and vomiting

What is the current status of trial NCT05546359?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 453 participants. The study started on 2024-01-18. Estimated completion is 2025-06-03.

What conditions does trial NCT05546359 study?

This clinical trial studies the following conditions: Nausea and Vomiting, Postoperative.

What interventions are being tested in trial NCT05546359?

The interventions under investigation include: Dexamethasone (DRUG), Amisulpride Injection (DRUG).

Who is sponsoring clinical trial NCT05546359?

This trial is sponsored by Acacia Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05546359 being conducted?

This trial has 14 study locations across Alabama, Georgia, Minnesota, Pennsylvania, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Nausea and Vomiting, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Nausea and Vomiting, Postoperative

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.